SlideShare a Scribd company logo
1 of 35
Download to read offline
SOCIAL SECTOR
  MICROFRANCHISING:
How the Ideas Behind McDonald’s
   Can Help Save the World
                 Justin Berk
        Yale MPH Candidate 2011
           justin.berk@yale.edu
Burden of Disease




A short list of treatable diseases accounts for
  70% of all childhood illness and death in the
  developing world. (Black, Morris, and Bryce 2003)
THE PROBLEM:
Only 35% of the populations in developing
    countries have access to essential
           medicines. (WHO 2009)


Over 50% of the drugs in the market are
 counterfeit or sub-standard. (WHO 2009)
Disease Burden of Treatable Illnesses




  Data taken from WHO Global Burden of Disease: 2004 update (2008)
Treatments are Affordable.
                               Estimated Annual              Estimated Cost of
        Disease
                                 Deaths (2004)                  Single Dose

         Malaria                       860,000                    $0.83 / £0.53

  Diarrheal Disease                   1,810,000                   $0.09 / £0.06

Respiratory Infections                2,940,000                   $0.10 / £0.06

          Total                      5,610,000                        <£1.00


- Death statistics from WHO 2008
- Treatment costs based on calculated averages taken from the HealthStore Foundation
Why is this happening?

•  The public system is broken.

•  NGOs have limited capacity.

•  Private markets exploit the poor.
Government Clinic Inefficiencies




                                             Courtesy of HealthStore Foundation

The average public sector availability of generic medicines ranged from 30% to 54%
across WHO regions. (Cameron et al. 2009)
Lack of Consumer Confidence
 India:
“No one uses public [health-care] facilities very much,
   and if anything, the poor use them less than the non-
   poor.” (Banerjee, Deaton, and Duflo 2004)

Uganda:
“Public health facilities were perceived to offer low
  quality care with chronic gaps such as shortages of
  essential supplies.” (Bakeera et al. 2009)
Limitations of the Charity Model

•  Charity creates dependence on
   external donor support
  – Accountable to donors, not beneficiaries


•  Grant conditions may restrict operations
Private Market Exploitation
•  Over 50% of drugs in
   developing countries are
   counterfeit (WHO 2006).

•  Private sector patients paid
   9–25 times international
   reference prices for generic
   products (Cameron et al. 2009).

•  No government regulation
The Social Innovation:



        The
Microfranchise Model
HealthStore’s
          “Three Point Test”
•  Standardization: ensure consistent quality
   to ensure effectiveness and gain confidence

•  Scalability: geometric growth to serve
   millions of customers or patients

•  Economies of scale: achieving lowest
   possible costs as the network grows
How It Works

                     Corporate
                     Franchisor



Franchisee    Franchisee    Franchisee   Franchisee
A Microfranchise
Through a business model of standardization:

•  Consistent quality

•  High customer volume

•  Low cost
•  Financial accountability
Franchisors provide:
•  Business manuals
Franchisors provide:
•  Business manuals

•  Regulations
Franchisors provide:
•  Business manuals

•  Regulations

•  Brand name
Franchisors provide:
•  Business manuals

•  Regulations

•  Brand name

•  Sometimes loans
The Franchise Model Passes
      the “Three Point Test”
•  Standardization: builds a brand name to
   ensure replicable quality at all outlets

•  Scalability: Subway scaled from 16 to over
   27,000 outlets in 86 countries in 33 years

•  Economies of scale: achieved in advertising,
   distribution, information systems, supplies etc.
Methods of Funding

  Grant       •  Lowest price
  based       •  Grant dependence


              •  Low price, no donor dependence
Sustainable   •  No access to private investment


              •  Greater access to investment capital
For-profit    •  Need for profit margins;
                 how much investor return?
Case Studies
  Two practical examples of the
social sector microfranchise model
HealthStore Foundation:
     The “Subway” Model
Living Goods:
 The “Avon” Model
Is it affordable to the poor?
Is it affordable to the poor?
•  HealthStore Foundation:
   Over 540,000 customers served

•  Base-of-Pyramid Health Sector: $158 Billion
  (Hammond et al. 2007)
   –  Currently non-competitive and inefficient
   –  Over 50% spent on pharmaceutical drugs
Is it profitable?
          HealthStore Foundation

2008: Of 59 CFW outlets, 88% reported a
profit (Beck, Deelder, and Miller 2010).

2010: HSF operates 85 locations:
82 in Kenya, 3 in Rwanda
Is it profitable?
                  Living Goods

Necessary Sales per Representative: $200/month
Average Rural Household in Uganda: 5.5 people
Households per representative: 200 (1100 people)

    $200 / 1100 people = 18 cents per month
Current Challenges
•  Need for “social investments”

•  Low market density in rural areas

•  Legal and regulatory obstacles

•  Competition with NGOs
A Cautionary Tale:
The Medicine Shoppe - India
How Microfranchising Works
    Problem           Microfranchise Solution
Counterfeits     Creates reliable brand name
Stock-outs       Incentives to maintain inventory
Corruption       Franchisor regulates and penalizes
Financial
                 No dependence on donors
Sustainability
Overcrowding     Reduces strain on public system
Affordability    Limited menu keeps costs low
How Microfranchising Works

It creates incentives that induce
franchisees to comply with
quality standards, then uses this
standardization to scale
exponentially.
Limitations
•  Does not reach the poorest of the poor;
   there is always a need for charity

•  A complement to the public system, not a
   replacement

•  Requires strict adherence to the franchise
   model
For the full paper




www.justinberk.com/senior-essay/




      justin.berk@yale.edu
Thank You

      -Justin Berk
justin.berk@yale.edu
References
Bakeera, Solome K et al. 2009. “Community perceptions and factors influencing utilization of health services in Uganda.”
     International Journal for Equity in Health 8(35). Available at: http://www.equityhealthj.com/content/8/1/25.
Banerjee, A., A. Deaton, and E. Duflo. 2004. “Health care delivery in rural Rajasthan.” Economic and Political Weekly: 944–
     949.
Beck, S., W. Deelder, and R. Miller. 2010. “Franchising in Frontier Markets: What's Working, What's Not, and Why.”
     Innovations:Technology, Governance, Globalization 5(1): 153–162.
Black, R. E, S. S Morris, and J. Bryce. 2003. “Where and why are 10 million children dying every year?.” The Lancet
     361(9376): 2226–2234.
Cameron, A. et al. 2009. “Medicine prices, availability, and affordability in 36 developing and middle-income countries: a
     secondary analysis.” The Lancet 373(9659): 240-249.
Hammond, A. L., Kramer, W. J., Katz, R. S., Tran, J. T., & Walker, C. 2007. The Next Four Billion: Market Size and Business
     Strategy at the Base of the Pyramid. Washington, DC: World Resources Institute and International Finance
     Corporation.
HealthStore Foundation, 2010. “The HealthStore Foundation” http://www.cfwshops.org/
Living Goods. 2010. “The Living Goods Model: A Sustainable System for Defeating Diseases of Poverty.” http://
     www.livinggoods.org
WHO. 2008. “The top 10 causes of death. Geneva: World Health Organization.” http://www.who.int/mediacentre/factsheets/
     fs310/en/index.html
WHO. 2009. “Access to affordable essential medicines.” In UN - MDG Gap Task Force 2009. http://www.who.int/medicines/
     mdg/en/index.html.

                                                                          Photos courtesy of HealthStore Foundation or Google Images

More Related Content

Viewers also liked

презентация для питера 4 7 сентября 2011
презентация для питера 4 7 сентября 2011презентация для питера 4 7 сентября 2011
презентация для питера 4 7 сентября 2011Sanek Chlus
 
Lo que me queda de vida1
Lo que me queda de vida1Lo que me queda de vida1
Lo que me queda de vida1miryamrugo
 
Agua o coca cola
Agua o coca colaAgua o coca cola
Agua o coca colaparambos
 
Р. Усманов: в Магаданский городской суд Замечания № 1750 на протокол судебног...
Р. Усманов: в Магаданский городской суд Замечания № 1750 на протокол судебног...Р. Усманов: в Магаданский городской суд Замечания № 1750 на протокол судебног...
Р. Усманов: в Магаданский городской суд Замечания № 1750 на протокол судебног...Irina Wickholm
 

Viewers also liked (6)

презентация для питера 4 7 сентября 2011
презентация для питера 4 7 сентября 2011презентация для питера 4 7 сентября 2011
презентация для питера 4 7 сентября 2011
 
Lo que me queda de vida1
Lo que me queda de vida1Lo que me queda de vida1
Lo que me queda de vida1
 
Agua o coca cola
Agua o coca colaAgua o coca cola
Agua o coca cola
 
Nagore 2 d
Nagore 2 dNagore 2 d
Nagore 2 d
 
Goodness Gateway - May 2015
Goodness Gateway - May 2015Goodness Gateway - May 2015
Goodness Gateway - May 2015
 
Р. Усманов: в Магаданский городской суд Замечания № 1750 на протокол судебног...
Р. Усманов: в Магаданский городской суд Замечания № 1750 на протокол судебног...Р. Усманов: в Магаданский городской суд Замечания № 1750 на протокол судебног...
Р. Усманов: в Магаданский городской суд Замечания № 1750 на протокол судебног...
 

Similar to How the Ideas Behind McDonald's Can Help Save the World

Advancing Research to Reduce Low-value Health Care
Advancing Research to Reduce Low-value Health CareAdvancing Research to Reduce Low-value Health Care
Advancing Research to Reduce Low-value Health CareThe Commonwealth Fund
 
Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...
Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...
Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...VATT Institute for Economic Research
 
The Economics of Quality in Healthcare
The Economics of Quality in HealthcareThe Economics of Quality in Healthcare
The Economics of Quality in HealthcareSage Growth Partners
 
Beyond Scaling Up: Supply chains
Beyond Scaling Up: Supply chainsBeyond Scaling Up: Supply chains
Beyond Scaling Up: Supply chainsIDS
 
Bma westminster lecture
Bma westminster lectureBma westminster lecture
Bma westminster lectureClive Peedell
 
Architecture Before Experience - EuroIA Amsterdam 2016
Architecture Before Experience - EuroIA Amsterdam 2016 Architecture Before Experience - EuroIA Amsterdam 2016
Architecture Before Experience - EuroIA Amsterdam 2016 Bogdan Stanciu
 
Where are healthcare cost savings
Where are healthcare cost savingsWhere are healthcare cost savings
Where are healthcare cost savingsBrian Ahier
 
Dr. William Behan, GP, Walkinstown
Dr. William Behan, GP, WalkinstownDr. William Behan, GP, Walkinstown
Dr. William Behan, GP, WalkinstownInvestnet
 
Arm debate short final 2010
Arm debate short final 2010Arm debate short final 2010
Arm debate short final 20103GDR
 
Presentation phr medications
Presentation phr medicationsPresentation phr medications
Presentation phr medicationstchenRN
 
Dynamics Impacting the Future of Healthcare
Dynamics Impacting the Future of HealthcareDynamics Impacting the Future of Healthcare
Dynamics Impacting the Future of Healthcareams345
 
Advanced health technologies and budgetary implications -- Valerie Paris, OECD
Advanced health technologies and budgetary implications -- Valerie Paris, OECDAdvanced health technologies and budgetary implications -- Valerie Paris, OECD
Advanced health technologies and budgetary implications -- Valerie Paris, OECDOECD Governance
 
Advanced health technologies and their budgetary implications - Valérie Paris...
Advanced health technologies and their budgetary implications - Valérie Paris...Advanced health technologies and their budgetary implications - Valérie Paris...
Advanced health technologies and their budgetary implications - Valérie Paris...OECD Governance
 
Session 4 American Healthcare - Meyer
Session 4   American Healthcare - MeyerSession 4   American Healthcare - Meyer
Session 4 American Healthcare - MeyerMedXellence
 
Session 4 - American Healthcare
Session 4 - American HealthcareSession 4 - American Healthcare
Session 4 - American HealthcareMedXellence
 
3º FÓRUM DA SAÚDE SUPLEMENTAR - CARMELLA BOCCHINO
3º FÓRUM DA SAÚDE SUPLEMENTAR - CARMELLA BOCCHINO3º FÓRUM DA SAÚDE SUPLEMENTAR - CARMELLA BOCCHINO
3º FÓRUM DA SAÚDE SUPLEMENTAR - CARMELLA BOCCHINOCNseg
 
Basics of Health Economics
Basics of Health EconomicsBasics of Health Economics
Basics of Health Economicseseidler
 

Similar to How the Ideas Behind McDonald's Can Help Save the World (20)

Advancing Research to Reduce Low-value Health Care
Advancing Research to Reduce Low-value Health CareAdvancing Research to Reduce Low-value Health Care
Advancing Research to Reduce Low-value Health Care
 
Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...
Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...
Prof. Martin Gaynor: Competition in Health Care and Health Insurance - Lesson...
 
The Economics of Quality in Healthcare
The Economics of Quality in HealthcareThe Economics of Quality in Healthcare
The Economics of Quality in Healthcare
 
Strategic thinking in health care
Strategic thinking in health careStrategic thinking in health care
Strategic thinking in health care
 
Beyond Scaling Up: Supply chains
Beyond Scaling Up: Supply chainsBeyond Scaling Up: Supply chains
Beyond Scaling Up: Supply chains
 
Bma westminster lecture
Bma westminster lectureBma westminster lecture
Bma westminster lecture
 
Architecture Before Experience - EuroIA Amsterdam 2016
Architecture Before Experience - EuroIA Amsterdam 2016 Architecture Before Experience - EuroIA Amsterdam 2016
Architecture Before Experience - EuroIA Amsterdam 2016
 
Where are healthcare cost savings
Where are healthcare cost savingsWhere are healthcare cost savings
Where are healthcare cost savings
 
Dr. William Behan, GP, Walkinstown
Dr. William Behan, GP, WalkinstownDr. William Behan, GP, Walkinstown
Dr. William Behan, GP, Walkinstown
 
Arm debate short final 2010
Arm debate short final 2010Arm debate short final 2010
Arm debate short final 2010
 
Where Is Healthcare Going? And How Will We Get There?
Where Is Healthcare Going? And How Will We Get There? Where Is Healthcare Going? And How Will We Get There?
Where Is Healthcare Going? And How Will We Get There?
 
Presentation phr medications
Presentation phr medicationsPresentation phr medications
Presentation phr medications
 
Dynamics Impacting the Future of Healthcare
Dynamics Impacting the Future of HealthcareDynamics Impacting the Future of Healthcare
Dynamics Impacting the Future of Healthcare
 
Advanced health technologies and budgetary implications -- Valerie Paris, OECD
Advanced health technologies and budgetary implications -- Valerie Paris, OECDAdvanced health technologies and budgetary implications -- Valerie Paris, OECD
Advanced health technologies and budgetary implications -- Valerie Paris, OECD
 
Advanced health technologies and their budgetary implications - Valérie Paris...
Advanced health technologies and their budgetary implications - Valérie Paris...Advanced health technologies and their budgetary implications - Valérie Paris...
Advanced health technologies and their budgetary implications - Valérie Paris...
 
Session 4 American Healthcare - Meyer
Session 4   American Healthcare - MeyerSession 4   American Healthcare - Meyer
Session 4 American Healthcare - Meyer
 
Session 4 - American Healthcare
Session 4 - American HealthcareSession 4 - American Healthcare
Session 4 - American Healthcare
 
3º FÓRUM DA SAÚDE SUPLEMENTAR - CARMELLA BOCCHINO
3º FÓRUM DA SAÚDE SUPLEMENTAR - CARMELLA BOCCHINO3º FÓRUM DA SAÚDE SUPLEMENTAR - CARMELLA BOCCHINO
3º FÓRUM DA SAÚDE SUPLEMENTAR - CARMELLA BOCCHINO
 
Health Care in Service Industry
Health Care in Service IndustryHealth Care in Service Industry
Health Care in Service Industry
 
Basics of Health Economics
Basics of Health EconomicsBasics of Health Economics
Basics of Health Economics
 

How the Ideas Behind McDonald's Can Help Save the World

  • 1. SOCIAL SECTOR MICROFRANCHISING: How the Ideas Behind McDonald’s Can Help Save the World Justin Berk Yale MPH Candidate 2011 justin.berk@yale.edu
  • 2. Burden of Disease A short list of treatable diseases accounts for 70% of all childhood illness and death in the developing world. (Black, Morris, and Bryce 2003)
  • 3. THE PROBLEM: Only 35% of the populations in developing countries have access to essential medicines. (WHO 2009) Over 50% of the drugs in the market are counterfeit or sub-standard. (WHO 2009)
  • 4. Disease Burden of Treatable Illnesses Data taken from WHO Global Burden of Disease: 2004 update (2008)
  • 5. Treatments are Affordable. Estimated Annual Estimated Cost of Disease Deaths (2004) Single Dose Malaria 860,000 $0.83 / £0.53 Diarrheal Disease 1,810,000 $0.09 / £0.06 Respiratory Infections 2,940,000 $0.10 / £0.06 Total 5,610,000 <£1.00 - Death statistics from WHO 2008 - Treatment costs based on calculated averages taken from the HealthStore Foundation
  • 6. Why is this happening? •  The public system is broken. •  NGOs have limited capacity. •  Private markets exploit the poor.
  • 7. Government Clinic Inefficiencies Courtesy of HealthStore Foundation The average public sector availability of generic medicines ranged from 30% to 54% across WHO regions. (Cameron et al. 2009)
  • 8. Lack of Consumer Confidence India: “No one uses public [health-care] facilities very much, and if anything, the poor use them less than the non- poor.” (Banerjee, Deaton, and Duflo 2004) Uganda: “Public health facilities were perceived to offer low quality care with chronic gaps such as shortages of essential supplies.” (Bakeera et al. 2009)
  • 9. Limitations of the Charity Model •  Charity creates dependence on external donor support – Accountable to donors, not beneficiaries •  Grant conditions may restrict operations
  • 10. Private Market Exploitation •  Over 50% of drugs in developing countries are counterfeit (WHO 2006). •  Private sector patients paid 9–25 times international reference prices for generic products (Cameron et al. 2009). •  No government regulation
  • 11. The Social Innovation: The Microfranchise Model
  • 12. HealthStore’s “Three Point Test” •  Standardization: ensure consistent quality to ensure effectiveness and gain confidence •  Scalability: geometric growth to serve millions of customers or patients •  Economies of scale: achieving lowest possible costs as the network grows
  • 13. How It Works Corporate Franchisor Franchisee Franchisee Franchisee Franchisee
  • 14. A Microfranchise Through a business model of standardization: •  Consistent quality •  High customer volume •  Low cost •  Financial accountability
  • 16. Franchisors provide: •  Business manuals •  Regulations
  • 17. Franchisors provide: •  Business manuals •  Regulations •  Brand name
  • 18. Franchisors provide: •  Business manuals •  Regulations •  Brand name •  Sometimes loans
  • 19. The Franchise Model Passes the “Three Point Test” •  Standardization: builds a brand name to ensure replicable quality at all outlets •  Scalability: Subway scaled from 16 to over 27,000 outlets in 86 countries in 33 years •  Economies of scale: achieved in advertising, distribution, information systems, supplies etc.
  • 20. Methods of Funding Grant •  Lowest price based •  Grant dependence •  Low price, no donor dependence Sustainable •  No access to private investment •  Greater access to investment capital For-profit •  Need for profit margins; how much investor return?
  • 21. Case Studies Two practical examples of the social sector microfranchise model
  • 22. HealthStore Foundation: The “Subway” Model
  • 23. Living Goods: The “Avon” Model
  • 24. Is it affordable to the poor?
  • 25. Is it affordable to the poor? •  HealthStore Foundation: Over 540,000 customers served •  Base-of-Pyramid Health Sector: $158 Billion (Hammond et al. 2007) –  Currently non-competitive and inefficient –  Over 50% spent on pharmaceutical drugs
  • 26. Is it profitable? HealthStore Foundation 2008: Of 59 CFW outlets, 88% reported a profit (Beck, Deelder, and Miller 2010). 2010: HSF operates 85 locations: 82 in Kenya, 3 in Rwanda
  • 27. Is it profitable? Living Goods Necessary Sales per Representative: $200/month Average Rural Household in Uganda: 5.5 people Households per representative: 200 (1100 people) $200 / 1100 people = 18 cents per month
  • 28. Current Challenges •  Need for “social investments” •  Low market density in rural areas •  Legal and regulatory obstacles •  Competition with NGOs
  • 29. A Cautionary Tale: The Medicine Shoppe - India
  • 30. How Microfranchising Works Problem Microfranchise Solution Counterfeits Creates reliable brand name Stock-outs Incentives to maintain inventory Corruption Franchisor regulates and penalizes Financial No dependence on donors Sustainability Overcrowding Reduces strain on public system Affordability Limited menu keeps costs low
  • 31. How Microfranchising Works It creates incentives that induce franchisees to comply with quality standards, then uses this standardization to scale exponentially.
  • 32. Limitations •  Does not reach the poorest of the poor; there is always a need for charity •  A complement to the public system, not a replacement •  Requires strict adherence to the franchise model
  • 33. For the full paper www.justinberk.com/senior-essay/ justin.berk@yale.edu
  • 34. Thank You -Justin Berk justin.berk@yale.edu
  • 35. References Bakeera, Solome K et al. 2009. “Community perceptions and factors influencing utilization of health services in Uganda.” International Journal for Equity in Health 8(35). Available at: http://www.equityhealthj.com/content/8/1/25. Banerjee, A., A. Deaton, and E. Duflo. 2004. “Health care delivery in rural Rajasthan.” Economic and Political Weekly: 944– 949. Beck, S., W. Deelder, and R. Miller. 2010. “Franchising in Frontier Markets: What's Working, What's Not, and Why.” Innovations:Technology, Governance, Globalization 5(1): 153–162. Black, R. E, S. S Morris, and J. Bryce. 2003. “Where and why are 10 million children dying every year?.” The Lancet 361(9376): 2226–2234. Cameron, A. et al. 2009. “Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.” The Lancet 373(9659): 240-249. Hammond, A. L., Kramer, W. J., Katz, R. S., Tran, J. T., & Walker, C. 2007. The Next Four Billion: Market Size and Business Strategy at the Base of the Pyramid. Washington, DC: World Resources Institute and International Finance Corporation. HealthStore Foundation, 2010. “The HealthStore Foundation” http://www.cfwshops.org/ Living Goods. 2010. “The Living Goods Model: A Sustainable System for Defeating Diseases of Poverty.” http:// www.livinggoods.org WHO. 2008. “The top 10 causes of death. Geneva: World Health Organization.” http://www.who.int/mediacentre/factsheets/ fs310/en/index.html WHO. 2009. “Access to affordable essential medicines.” In UN - MDG Gap Task Force 2009. http://www.who.int/medicines/ mdg/en/index.html. Photos courtesy of HealthStore Foundation or Google Images